HPV Testing in Older Women for Cervical Cancer Screening
Author Information
Author(s): Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan W-K, Krausz T, Soutter P
Primary Institution: Imperial Cancer Research Fund
Hypothesis
Can HPV testing improve the detection of high-grade cervical intraepithelial neoplasia in women aged 35 or over?
Conclusion
HPV testing can enhance the detection of cervical abnormalities in older women, with the newer Hybrid Capture II microtitre test showing promising results.
Supporting Evidence
- HPV testing showed 86% sensitivity for detecting high-grade CIN in women with borderline or worse cytology.
- The newer Hybrid Capture II microtitre test had a 95% sensitivity and a low false positive rate.
- Cytology performed well in detecting cervical abnormalities in the older cohort.
Takeaway
This study looked at how testing for HPV can help find cervical cancer in older women. It found that a new test works really well.
Methodology
Women aged 34 or more were tested for HPV in addition to routine cytology, with samples analyzed using PCR and Hybrid Capture tests.
Potential Biases
Potential bias in the selection of participants from general practitioner practices.
Limitations
The study primarily focused on women aged 35 and over, which may limit generalizability to younger populations.
Participant Demographics
Women aged 34 or more attending for routine smear tests.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website